Tag: neurostimulation

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. – INSP

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Obtient l’Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l’Apnée Obstructive du Sommeil

INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025.

Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and Australian Clinical Programs Following Strong Pilot Data

- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins
- Series B round in planning to support pivotal U.S. trial
- New CEO appointment signals next phase of growth and expansion

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsNeurostimulation

Back to Smart: Hisense Rolls Out Back-to-School Deals Across the GCC

UCLOUDLINK GROUP INC. Announces Unaudited Second Quarter 2025 Financial Results

U.S. Portable Power Station Market Research Report 2025-2030 | Smart Tech Revolutionizing the Industry, Boosting Expansion

Tag: neurostimulation

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. – INSP

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Nyxoah Obtient l’Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l’Apnée Obstructive du Sommeil

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and Australian Clinical Programs Following Strong Pilot Data

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us